Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Ford

Showing results (141-150 of 156) with videos related to

Pageof 16
Sort By:
European Journal of Neurology|October 5, 2020
Polypharmacy, functional outcome and treatment effect of intravenous alteplase for acute ischaemic strokeM Jensen, F Boutitie, B Cheng, et al.
The American Journal of Cardiology|November 24, 1999
The design of a prospective study of Pravastatin in the Elderly at Risk (PROSPER). PROSPER Study Group. PROspective Study of Pravastatin in the Elderly at RiskJ Shepherd, G J Blauw, M B Murphy, et al.
Human Reproduction (Oxford, England)|June 3, 2011
Gynaecological endoscopic evaluation of 4% icodextrin solution: a European, multicentre, double-blind, randomized study of the efficacy and safety in the reduction of de novo adhesions after laparoscopic gynaecological surgeryG Trew, G Pistofidis, G Pados, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 18, 2002
Testing cognitive function in elderly populations: the PROSPER study. PROspective Study of Pravastatin in the Elderly at RiskP J Houx, J Shepherd, G-J Blauw, et al.
Annals of the New York Academy of Sciences|April 27, 2007
Genetic variation in the interleukin-10 gene promoter and risk of coronary and cerebrovascular events: the PROSPER studyS Trompet, D Pons, A J M DE Craen, et al.
BMC Endocrine Disorders|September 21, 2018
Study protocol: a randomised controlled trial on the clinical effects of levothyroxine treatment for subclinical hypothyroidism in people aged 80 years and overR S Du Puy, I Postmus, D J Stott, et al.
Plos One|May 20, 2022
Resting heart rate and incident atrial fibrillation: A stratified Mendelian randomization in the AFGen consortiumJ E Siland, B Geelhoed, C Roselli, et al.
The Pharmacogenomics Journal|December 7, 2019
Genome-wide meta-analysis of variant-by-diuretic interactions as modulators of lipid traits in persons of European and African ancestryLisa de las Fuentes, Y J Sung, C M Sitlani, et al.
The Pharmacogenomics Journal|March 6, 2013
Drug-gene interactions and the search for missing heritability: a cross-sectional pharmacogenomics study of the QT intervalC L Avery, C M Sitlani, D E Arking, et al.
The Pharmacogenomics Journal|July 19, 2017
Pharmacogenomics study of thiazide diuretics and QT interval in multi-ethnic populations: the cohorts for heart and aging research in genomic epidemiologyA A Seyerle, C M Sitlani, R Noordam, et al.
Pageof 16

Showing results (141-150 of 156) with videos related to

Sort By:
Pageof 16
European Journal of Neurology|October 5, 2020
Polypharmacy, functional outcome and treatment effect of intravenous alteplase for acute ischaemic strokeM Jensen, F Boutitie, B Cheng, et al.
The American Journal of Cardiology|November 24, 1999
The design of a prospective study of Pravastatin in the Elderly at Risk (PROSPER). PROSPER Study Group. PROspective Study of Pravastatin in the Elderly at RiskJ Shepherd, G J Blauw, M B Murphy, et al.
Human Reproduction (Oxford, England)|June 3, 2011
Gynaecological endoscopic evaluation of 4% icodextrin solution: a European, multicentre, double-blind, randomized study of the efficacy and safety in the reduction of de novo adhesions after laparoscopic gynaecological surgeryG Trew, G Pistofidis, G Pados, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 18, 2002
Testing cognitive function in elderly populations: the PROSPER study. PROspective Study of Pravastatin in the Elderly at RiskP J Houx, J Shepherd, G-J Blauw, et al.
Annals of the New York Academy of Sciences|April 27, 2007
Genetic variation in the interleukin-10 gene promoter and risk of coronary and cerebrovascular events: the PROSPER studyS Trompet, D Pons, A J M DE Craen, et al.
BMC Endocrine Disorders|September 21, 2018
Study protocol: a randomised controlled trial on the clinical effects of levothyroxine treatment for subclinical hypothyroidism in people aged 80 years and overR S Du Puy, I Postmus, D J Stott, et al.
Plos One|May 20, 2022
Resting heart rate and incident atrial fibrillation: A stratified Mendelian randomization in the AFGen consortiumJ E Siland, B Geelhoed, C Roselli, et al.
The Pharmacogenomics Journal|December 7, 2019
Genome-wide meta-analysis of variant-by-diuretic interactions as modulators of lipid traits in persons of European and African ancestryLisa de las Fuentes, Y J Sung, C M Sitlani, et al.
The Pharmacogenomics Journal|March 6, 2013
Drug-gene interactions and the search for missing heritability: a cross-sectional pharmacogenomics study of the QT intervalC L Avery, C M Sitlani, D E Arking, et al.
The Pharmacogenomics Journal|July 19, 2017
Pharmacogenomics study of thiazide diuretics and QT interval in multi-ethnic populations: the cohorts for heart and aging research in genomic epidemiologyA A Seyerle, C M Sitlani, R Noordam, et al.
Pageof 16